|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
April 14, 2006
Novantrone: Teva Pharmaceutical said its generic version of Serono SA's Novantrone injection has been approved by the FDA. :
" Shipment of the product, which is indicated for use in combination with corticosteroids as initial therapy for the treatment of patients with pain related to advanced hormone-refractory prostate cancer, as well as in combination with other approved products for the initial therapy of acute nonlymphocytic leukemia in adults, will begin immediately." |